Most Recent Articles by Laura Entis
Gilead wins reversal of $2.5 billion payment order; Aimmune Therapeutics' peanut allergy therapy shows promise; AstraZeneca wins FDA approval on key cancer drug.
Amazon moves into medical supply market; Big Pharma gets a tax cut; Former Celgene CEO plans Senate run.
As the evidence mounts that high-deductibles don't cause patients to shop or save for healthcare, payers are taking note.
White House limits guidance documents; Top executives exit Axovant; Carroll nominated as drug czar.
Study: Two prostate cancer drugs delay metastasis by two years; Budget deal funds CHIP for four years; Azar outlines Trump's drug pricing plans.